# Azafaros funding rounds and investors

As of 14 Oct 2026, Azafaros has raised $146.7M across 1 verified round on record (amounts in other currencies converted to USD); latest: €132M Series B led by Forbion Growth and Jeito Capital, announced 13 May 2025.

Azafaros develops therapeutics for patients with rare metabolic disorders, particularly those affecting the lysosomal storage system.

Website: https://azafaros.com  
Headquarters: Leiden, Netherlands  
Page: https://fireround.dev/companies/azafaros.com

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2025-05-13 | Series B | €132M | Forbion Growth, Jeito Capital | BioGeneration Ventures, Pictet, Schroders Capital, Seroba | [azafaros.com](https://www.azafaros.com/news-media/azafaros-secures-132m-in-oversubscribed-series-b-financing-to-advance-phase-3-clinical-programs-of-innovative-therapies-in-lysosomal-storage-disorders/l211c14), [biospace.com](https://www.biospace.com/press-releases/azafaros-secures-132m-in-oversubscribed-series-b-financing-to-advance-phase-3-clinical-programs-of-innovative-therapies-in-lysosomal-storage-disorders) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.